| Fiscal period | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Period End Date | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 |
|---|
| Sales | 1,074.75 | 963.88 | 994.85 | 882.75 | 727.85 | 603.84 | 542.15 | 509.69 | 449.05 | 394.29 |
| Total Revenues | 1,074.75 | 963.88 | 994.85 | 882.75 | 727.85 | 603.84 | 542.15 | 509.69 | 449.05 | 394.29 |
| Cost of sales | 589.42 | 562.70 | 562.49 | 487.98 | 401.60 | 338.81 | 306.37 | 284.47 | 254.68 | 212.30 |
| Gross Profit | 485.33 | 401.18 | 432.37 | 394.77 | 326.25 | 265.03 | 235.78 | 225.22 | 194.37 | 181.99 |
| Goodwill impairment charge | -- | -- | -- | -- | -- | -- | -- | 1.10 | -- | -- |
| Intangible asset impairment charge | -- | -- | -- | -- | 0.81 | -- | -- | -- | -- | -- |
| Research and development | 71.25 | 57.54 | 65.62 | 59.53 | 51.40 | 45.23 | 40.81 | 36.63 | 33.89 | 27.80 |
| Acquired in-process research and development | 0.00 | 0.25 | 0.53 | 0.64 | 12.14 | 0.46 | 1.00 | -- | 0.00 | 2.45 |
| Severance costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 335.69 | 297.72 | 327.27 | 276.02 | 229.13 | 184.40 | 156.35 | 147.89 | 128.64 | 122.11 |
| Legal settlement | (10.04) | (18.68) | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- |
| Impairment | (4.28) | (36.50) | (23.75) | (0.66) | -- | -- | 0.00 | -- | (8.09) | -- |
| Gain on sale of land | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Contingent consideration benefit | (3.16) | 7.96 | 0.23 | 0.70 | 0.30 | (0.06) | (0.08) | 0.57 | 4.09 | -- |
| Total Operating Expenses | 424.42 | 402.74 | 416.93 | 336.15 | 293.18 | 230.15 | 198.24 | 185.06 | 166.52 | 152.35 |
| Operating Income (Loss) | 60.92 | (1.56) | 15.43 | 58.62 | 33.07 | 34.88 | 37.54 | 40.17 | 27.84 | 29.64 |
| Interest expense | 5.26 | 9.99 | 12.41 | 10.36 | 7.74 | 8.80 | 6.23 | 8.83 | 8.04 | 0.60 |
| Litigation settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | 0.77 | 0.60 | (0.29) | 1.20 | 0.38 | 0.08 | 0.27 | 0.22 | 0.26 | 0.23 |
| Other income (expense) | (2.51) | (2.28) | (0.54) | 0.06 | (0.87) | (0.77) | (0.39) | 0.02 | (0.22) | (1.65) |
| Bargain purchase gain | -- | -- | -- | -- | 11.04 | -- | 0.00 | -- | -- | -- |
| Total other Income (Expense) | (7.00) | (11.67) | (13.24) | (9.10) | 2.81 | (9.49) | (6.34) | (8.59) | -- | -- |
| Income (loss) before income taxes | 53.92 | (13.23) | 2.19 | 49.52 | 35.88 | 25.39 | 31.20 | 31.57 | 19.84 | 27.62 |
| Income tax expense (benefit) | 5.46 | (3.39) | (3.26) | 7.50 | 8.36 | 5.27 | 7.40 | 8.60 | 3.27 | 7.91 |
| Current tax expense: Foreign | 8.48 | 8.41 | 8.04 | 6.00 | 5.17 | -- | 3.22 | -- | 2.32 | 1.00 |
| Current tax expense: Federal | 0.81 | (0.94) | 0.48 | (1.13) | 3.85 | -- | (0.02) | -- | (0.75) | 5.35 |
| Current tax expense: State | 0.81 | 0.44 | 0.66 | 0.58 | 0.65 | -- | 0.75 | -- | 0.33 | 1.01 |
| Deferred (benefit) expense: Federal | (0.47) | (2.69) | (8.11) | 4.40 | (0.31) | -- | 3.25 | -- | 1.09 | 0.87 |
| Deferred (benefit) expense: State | (1.85) | (4.52) | (3.52) | (0.67) | (0.22) | -- | 0.29 | -- | 0.28 | (0.34) |
| Deferred (benefit) expense: Foreign | (2.32) | (4.08) | (0.80) | (1.68) | (0.77) | -- | (0.09) | -- | (0.01) | 0.02 |
| Minority interest in income of subsidiary | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) Available to Common Shareholders | 48.45 | (9.84) | 5.45 | 42.02 | 27.52 | 20.12 | 23.80 | 22.97 | 16.57 | 19.71 |
| Net Earnings Per Share (Basic) | 0.86 | (0.18) | 0.10 | 0.80 | 0.56 | 0.45 | 0.54 | 0.53 | 0.39 | 0.47 |
| Net Earnings Per Share (Diluted) | 0.84 | (0.18) | 0.10 | 0.78 | 0.55 | 0.45 | 0.53 | 0.53 | 0.39 | 0.46 |
| Weighted Average Shares Outstanding (Basic) | 56.15 | 55.43 | 55.08 | 52.27 | 48.81 | 44.41 | 44.04 | 43.14 | 42.61 | 42.18 |
| Weighted Average Shares Outstanding (Diluted) | 57.36 | 55.43 | 56.24 | 53.93 | 50.10 | 44.86 | 44.51 | 43.41 | 42.88 | 42.61 |